SPDR S&P Biotech (XBI)

Add to Watchlists
Create an Alert
61.10 +0.71  +1.18% NYSE Arca Aug 26, 20:00 Delayed 2m USD
View Full Chart
XBI Price Chart

XBI Key Stats

Expense Ratio 0.35%
Share Class Assets Under Management 2.129B
30-Day Average Daily Volume Upgrade
Net Asset Value 61.93
Discount or Premium to NAV 0.02%
Turnover Ratio 78.00

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.10% 0.10% 0.00%
Stock 99.90% 99.90% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Aug. 25, 2016

XBI Net Fund Flows

1M 6.868M
3M 86.97M
6M 255.49M
YTD 171.52M
1Y -106.16M
3Y 829.55M
5Y 828.62M
10Y 1.397B
As of July 31, 2016

XBI Net Share Class Flows

1M 6.868M
3M 86.97M
6M 255.49M
YTD 171.52M
1Y -106.16M
3Y 829.55M
5Y 828.62M
10Y 1.397B
As of July 31, 2016

XBI Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00%
Greater Europe 0.00%
United Kingdom 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Aug. 25, 2016
Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Aug. 25, 2016

XBI Stock Market Capitalization

Giant 9.38%
Large 9.77%
Medium 27.21%
Small 34.22%
Micro 19.28%
As of Aug. 25, 2016

XBI Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.00%
Large Cap Growth 20.70%
Mid Cap Value 2.70%
Mid Cap Blend 2.69%
Mid Cap Growth 24.03%
Small Cap Value 2.15%
Small Cap Blend 11.08%
Small Cap Growth 36.64%
As of Aug. 25, 2016
View More Holdings

XBI Top 10 Holdings

Symbol Name % Weight Price % Chg
IONS Ionis Pharmaceuticals Inc 3.15% 30.90 +1.75%
MDVN Medivation Inc 3.02% 80.35 +0.14%
SRPT Sarepta Therapeutics Inc 2.91% 26.78 +3.96%
BIIB Biogen Inc 2.81% 308.17 +0.43%
BMRN Biomarin Pharmaceutical Inc 2.64% 96.22 +1.32%
UTHR United Therapeutics Corp 2.50% 121.76 -1.22%
BLUE bluebird bio Inc 2.50% 51.23 +2.52%
TSRO Tesaro Inc 2.49% 86.46 +1.44%
AMGN Amgen Inc 2.48% 171.97 +1.02%
ALNY Alnylam Pharmaceuticals Inc 2.48% 70.80 +2.09%
As of Aug. 25, 2016
Advertisement

One Page Reports

XBI Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD
100.0%

XBI Manager Info

Name Tenure
John Tucker 10.50 yrs
Karl Schneider 1.75 yrs
Michael Feehily 4.75 yrs

XBI Risk Info

Beta 1.438
Max Drawdown (All) 49.39%
Historical Sharpe (10Y) 0.7237
Historical Sortino (All) 0.9252
30-Day Rolling Volatility 28.06%
Daily Value at Risk (VaR) 1% (All) 4.95%
Monthly Value at Risk (VaR) 1% (All) 21.66%

XBI Fundamentals

Dividend Yield TTM (8-26-16) 0.49%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 9.429
Weighted Average Price to Book Ratio 5.247
Weighted Median ROE -6.52%
Weighted Median ROA -12.34%
Forecasted Dividend Yield 0.16%
Forecasted PE Ratio 21.35
Forecasted Price to Sales Ratio 7.785
Forecasted Price to Book Ratio 2.664
Number of Holdings 88
As of Aug. 25, 2016

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 26.62%
Forecasted Book Value Growth 28.72%
Forecasted Cash Flow Growth 32.57%
Forecasted Earnings Growth 32.17%
Forecasted Revenue Growth 19.73%
As of Aug. 25, 2016

XBI Performance

  Returns Total Returns
1M 2.04% 2.04%
3M 8.68% 8.77%
6M 23.68% 23.93%
1Y -16.30% -15.90%
3Y 49.87% 53.02%
5Y 204.7% 212.1%
As of Aug. 17, 2016

XBI Comparables

Edit

XBI Attributes

Key Dates
Inception Date 1/31/2006
Last Annual Report Date 6/30/2015
Last Prospectus Date 2/3/2015
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XBI Excel Add-In Codes

  • Name: =YCI("XBI","name")
  • Broad Asset Class: =YCI("XBI", "broad_asset_class")
  • Broad Category: =YCI("XBI", "broad_category_group")
  • Prospectus Objective: =YCI("XBI", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.